TILUDRONATE (tye LOO droe nate) slows calcium loss from bone. It helps to make healthy bone and to slow bone loss in patients with Paget's disease.
Tiludronic acid is a bisphosphonate used for treatment of Paget's disease of bone
(osteitis deformans) in human medicine. It has the tradename Skelid.
Easy to read patient leaflet for tiludronate. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Nov 15, 2015 ... Tiludronate: learn about side effects, dosage, special precautions, and more on
Tiludronate affects calcium metabolism and inhibits bone resorption and soft
tissue calcification. Of the tiludronate that is resorbed (from oral preparation) or ...
Apr 14, 2010 ... SKELID (tiludronate) is a bisphosphonate characterized by a (4-chlorophenylthio
) group on the carbon atom of the basic P-C-P structure ...
SKELID tablets for oral administration contain 240 mg tiludronate disodium,
which is the molar equivalent of 200 mg tiludronic acid. SKELID tablets also
Medscape - Indication-specific dosing for Skelid (tiludronate), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...
Apr 10, 2008 ... Tiludronate is a compound in the bisphosphonate class of drugs. The main
pharmacologic action of bisphosphonates is to inhibit bone ...
Tiludronate is only found in individuals that have used or taken this drug. It is a
bisphosphonate characterized by a (4-chlorophenylthio) group on the carbon ...